Literature DB >> 2115420

The influence of prednisolone on the recirculation of peripheral blood lymphocytes in vivo.

E Bloemena1, S Weinreich, P T Schellekens.   

Abstract

In humans and in laboratory animals, administration of a single does of glucocorticosteroids induces a rapid and transient decrease in the numbers of peripheral blood lymphocytes through a redistribution of circulating lymphocytes. This lymphocytopenic effect is an important factor in the immunosuppressive capacity of corticosteroids. We have investigated whether the redistribution is due to an increased influx of circulating lymphocytes from the blood into the lymphoid organs or to a decreased efflux from the organs. Fluoresceinated lymphocytes were injected intravenously in unrestrained normal and prednisolone-treated rabbits and the distribution curves in the peripheral blood were analysed on the basis of a two-compartment model (known from pharmacokinetic studies). In this way, it is shown that the rapid fall in peripheral blood lymphocyte numbers induced by prednisolone is due to a decreased efflux of circulating lymphocytes from the lymphoid organs. In addition, it is demonstrated that prolonged infusion of prednisolone leads to an altered distribution pattern of the circulating lymphocytes among the organs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115420      PMCID: PMC1535213          DOI: 10.1111/j.1365-2249.1990.tb03310.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Acute myocardial infarction due to childhood lymphoma.

Authors:  G C Bagby; R D Goldman; H C Newman; J F Means
Journal:  N Engl J Med       Date:  1972-08-17       Impact factor: 91.245

2.  Cytotoxic T lymphocytes and glucocorticoids activate an endogenous suicide process in target cells.

Authors:  D S Ucker
Journal:  Nature       Date:  1987 May 7-13       Impact factor: 49.962

3.  Ecotaxis: the principle and its application to the study of Hodgkin's disease.

Authors:  M D Sousa; M Yang; E Lopes-Corrales; C Tan; J A Hansen; B Dupont; R A Good
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

Review 4.  Glucocorticosteroids and organ transplantation.

Authors:  E Dupont; J Wybran; C Toussaint
Journal:  Transplantation       Date:  1984-04       Impact factor: 4.939

5.  The migration of lymphocytes across specialized vascular endothelium. IV. Prednisolone acts at several points on the recirculation pathways of lymphocytes.

Authors:  J H Cox; W L Ford
Journal:  Cell Immunol       Date:  1982-01-15       Impact factor: 4.868

6.  Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death.

Authors:  J J Cohen; R C Duke
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

7.  Direct fluorescent labeling of cells with fluorescein or rhodamine isothiocyanate. II. Potential application to studies of lymphocyte migration and maturation.

Authors:  E C Butcher; R G Scollay; I L Weissman
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

8.  A catheter system for long-term intravenous infusion in unrestrained rats.

Authors:  U Brenner; J M Müller; M Walter; H W Keller
Journal:  Lab Anim       Date:  1985-07       Impact factor: 2.471

9.  Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and b lymphocytes to the bone marrow.

Authors:  A S Fauci
Journal:  Immunology       Date:  1975-04       Impact factor: 7.397

10.  Human lymphocyte traffic assessed by indium-111 oxine labelling: clinical observations.

Authors:  J Wagstaff; C Gibson; N Thatcher; W L Ford; H Sharma; D Crowther
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

View more
  13 in total

1.  Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects.

Authors:  E M Martínez-Cáceres; M A Barrau; L Brieva; C Espejo; N Barberà; X Montalban
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

2.  Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in adrenalectomized rats.

Authors:  G M Ferron; N A Pyszczynski; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1999-02

3.  Murine Glucocorticoid Receptors Orchestrate B Cell Migration Selectively between Bone Marrow and Blood.

Authors:  Derek W Cain; Carl D Bortner; David Diaz-Jimenez; Maria G Petrillo; Amanda Gruver-Yates; John A Cidlowski
Journal:  J Immunol       Date:  2020-06-22       Impact factor: 5.422

4.  Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race.

Authors:  M H Magee; R A Blum; C D Lates; W J Jusko
Journal:  J Clin Pharmacol       Date:  2001-11       Impact factor: 3.126

5.  Pharmacokinetic/pharmacodynamic model for prednisolone inhibition of whole blood lymphocyte proliferation.

Authors:  Mindy He Magee; Robert A Blum; Christian D Lates; William J Jusko
Journal:  Br J Clin Pharmacol       Date:  2002-05       Impact factor: 4.335

6.  Social behavior effects of diphenyl dimethyl bicarboxylate (DDB) in the sensory contact model.

Authors:  Amal M Mahfoz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-28       Impact factor: 3.000

7.  Two-compartment basophil cell trafficking model for methylprednisolone pharmacodynamics.

Authors:  J A Wald; D E Salazar; H Y Chen; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

8.  Lymphocyte subpopulations, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome.

Authors:  S A Hulton; V Shah; M R Byrne; G Morgan; T M Barratt; M J Dillon
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

Review 9.  Glucocorticoids and immune checkpoint inhibitors in glioblastoma.

Authors:  William J Kelly; Mark R Gilbert
Journal:  J Neurooncol       Date:  2020-02-27       Impact factor: 4.130

10.  Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover study.

Authors:  Dona L Fleishaker; Arnab Mukherjee; Fredrick S Whaley; Shanthini Daniel; Bernhardt G Zeiher
Journal:  BMC Musculoskelet Disord       Date:  2016-07-16       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.